Literature DB >> 21070313

Levothyroxine replacement therapy and refractory hypotension out of transitional period in preterm infants.

Junichiro Okada1, Sachiko Iwata, Akiko Hirose, Hiroshi Kanda, Makoto Yoshino, Yasuki Maeno, Toyojiro Matsuishi, Osuke Iwata.   

Abstract

BACKGROUND: Recent studies suggest that refractory hypotension from causes other than septicaemia or cardiac failure is common in extremely preterm infants even out of the transitional period. Marked response to low-dose cortisol suggests underlying adrenal insufficiency, although the exact mechanism remains unknown.
METHODS: To investigate potential triggers for and related short-term outcomes of early-onset (<Day 7) and late-onset (≥Day 7) refractory hypotension, clinical data for 70 infants <30 weeks gestation were assessed.
RESULTS: The incidence of early-onset refractory hypotension (n=7) was correlated with younger gestational ages <26 weeks (P < 0.05), whereas the incidence of late-onset refractory hypotension (n=14) was correlated with younger gestational ages and levothyroxine supplementation (P<0.05 and 0.01, respectively). The incidence of both early- and late-onset refractory hypotension was correlated with risks of short-term adverse outcomes such as prolonged mechanical ventilation and hospital stay.
CONCLUSIONS: Levothyroxine supplementation was identified as an independent variable correlated with an increased incidence of refractory hypotension out of the transitional period; as seen in hypothyroidism with Addison's disease, the immature hypothalamic-pituitary-adrenal axis may not respond properly to the increased demand for cortisol, which may precipitate premature infants into refractory hypotension. Following the administration of levothyroxine, preterm infants may have to be carefully monitored for early signs of refractory hypotension.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21070313     DOI: 10.1111/j.1365-2265.2010.03927.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity.

Authors:  A Yamamoto; M Kawai; K Iwanaga; T Matsukura; F Niwa; T Hasegawa; T Heike
Journal:  J Perinatol       Date:  2015-06-25       Impact factor: 2.521

2.  Thyroxine Threshold Is Linked to Impaired Outcomes in Preterm Infants.

Authors:  Stephanie Coquelet; Helene Deforge; Jean-Michel Hascoët
Journal:  Front Pediatr       Date:  2020-05-05       Impact factor: 3.418

3.  Postnatal Serum Total Thyroxine of Very Preterm Infants and Long-Term Neurodevelopmental Outcome.

Authors:  Yung-Chieh Lin; Chen-Yueh Wang; Yu-Wen Pan; Yen-Ju Chen; Wen-Hao Yu; Yen-Yin Chou; Chi-Hsien Huang; Wei-Ying Chu; Chyi-Her Lin; Osuke Iwata
Journal:  Nutrients       Date:  2021-03-24       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.